Reported by New York Post •
30 Mainstream framing provisional
Why this rating? · 1 signal

Signals flagged in the original

  • headline asserts a conclusion / scare-quotes

Provisional estimate — refines shortly Full breakdown ↓

Understanding Polyendocrine Metabolic Ovarian Syndrome: Diagnosis and Myths

Polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), affects 1 in 8 women of reproductive age and is often misdiagnosed due to its varied symptoms. The condition is complex and requires individualized treatment. Ongoing monitoring is essential for managing health risks associated with PMOS.

People
Jacquelyn Shaw, MD

Our neutral summary

Polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), affects 1 in 8 women of reproductive age and is often misdiagnosed due to its varied symptoms. The condition is complex and requires individualized treatment. Ongoing monitoring is essential for managing health risks associated with PMOS.

Read the full story at New York Post

The reporting belongs to New York Post; we don't reproduce it.

Annotating as

No note attached

on this article.

Language Analysis

Loaded-language score 30/100
wirepublicmainstream flavoredpartisanadvocacy
Inflammatory language 10/100

Loaded Language Removed

  • ✕ headline asserts a conclusion / scare-quotes

Original vs. Neutral

Original Headline

The biggest myths about a common women’s condition — and why it’s so difficult to diagnose

Neutral Headline

Understanding Polyendocrine Metabolic Ovarian Syndrome: Diagnosis and Myths